OncoHost to Present PROphet® Biomarker Model that Accurately Predicts Clinical Benefit to ICI-Based Treatment at ASCO 2023 ...Middle East

PR Newswire - Economy
OncoHost to Present PROphet® Biomarker Model that Accurately Predicts Clinical Benefit to ICI-Based Treatment at ASCO 2023
Plasma proteomic-based output complements tissue PD-L1 expression levels as a tool to assist therapeutic decisions for non-small cell lung cancer (NSCLC) patients BINYAMINA, Israel, May 25, 2023 /PRNewswire/ -- OncoHost, a technology company transforming the approach to precision medicine...

Hence then, the article about oncohost to present prophet biomarker model that accurately predicts clinical benefit to ici based treatment at asco 2023 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( OncoHost to Present PROphet® Biomarker Model that Accurately Predicts Clinical Benefit to ICI-Based Treatment at ASCO 2023 )

Apple Storegoogle play

Last updated :

Also on site :



Latest News